PKUCon 2027

18–20 March 2027
Barceló Málaga
Calle Héroe de Sostoa 2, 29002 Málaga, Spain
Register

Welcome to PKUCon 2027

PKUCon - Connecting the world of PKU - is an international forum designed to convene all stakeholders actively engaged in the management and care of individuals with phenylketonuria (PKU).

PKUCon 2027 will explore the evolving landscape of PKU and hyperphenylalaninaemias, moving beyond a single-disease, single-target and single-treatment model, with main focus on:

  • Diagnostic complexity
  • Brain and real-life outcomes
  • Treatment burden
  • Emerging pharmacological options
  • Nutritional strategies in the pharmacological era
  • Future therapeutic perspectives

Our mission

The aim of PKUCon 2027 is to discuss how different interventions can be selected, combined, monitored, and adapted according to phenotype, age, responsiveness, clinical needs, and patient priorities.

We are confident that this international event will provide a unique and valuable opportunity for networking and discussion among all colleagues dedicated to the management of PKU. We very much look forward to taking this journey with you.

See you in Málaga!

 

Register now

Meet our presidents

Nicola Longo, MD
Nicola Longo, MD
Clinical Genetics
University of California, Los Angeles, CA, United States
Ania C. Muntau, MD
Ania C. Muntau, MD
Paediatrics
University Children’s Hospital, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany
Valentina Rovelli, MD
Valentina Rovelli, MD
Paediatrics and Metabolic Medicine
Milan, Italy
18–20 March 2027
Barceló Málaga
Calle Héroe de Sostoa 2, 29002 Málaga, Spain